XML 44 R32.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Liability Related to Sale of Future Royalties (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Liability Related to Sale of Future Royalties [Abstract] |
Liability Related to Sale of Future Royalties | The following table sets forth information on our liability related to sale of future royalties (in thousands):
Proceeds from sale of future royalties in January 2023 |  | $ | 500,000 |
Issuance costs related to sale of future royalties |  |  | (10,434 | )
Royalty payments to Royalty Pharma |  |  | (44,628 | )
Interest expense related to sale of future royalties |  |  | 68,238 |
Amortization of issuance costs related to sale of future royalties |  |  | 560 |
Net liability related to sale of future royalties as of December 31, 2023 |  |  | 513,736 |
Royalty payments to Royalty Pharma |  |  | (16,236 | )
Interest expense related to sale of future royalties |  |  | 35,949 |
Amortization of issuance costs related to sale of future royalties |  |  | 305 |
Net liability related to sale of future royalties as of June 30, 2024 |  | $ | 533,754 |

X
- References No definition available. + Details
Name: | us-gaap_OtherLiabilitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of other noncurrent liabilities. + References No definition available. + Details
Name: | us-gaap_OtherNoncurrentLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration